4930488E11Rik Inhibitors

Tmsb15l Inhibitors is a chemical class including agents that can indirectly modify the function or expression of TMSB15L by influencing cellular pathways and processes related to actin dynamics. These chemicals do not specifically target TMSB15L; instead, they affect various aspects of actin filament formation and maintenance, which in turn can influence the role of TMSB15L within the cell.

Microtubule-stabilizing agents such as paclitaxel can interfere with the interplay between the microtubule and actin networks, indirectly affecting the role of TMSB15L in cellular dynamics. Actin polymerization inhibitors like cytochalasin D, latrunculin A, and chondramide can disrupt actin filament assembly, potentially impacting TMSB15L-associated processes. Jasplakinolide and phalloidin, by stabilizing actin filaments, can alter the equilibrium of actin polymerization and depolymerization, thereby affecting TMSB15L activity. Inhibitors of actin-myosin contractility such as blebbistatin and ML-7 can change actomyosin dynamics, which might alter the cellular context in which TMSB15L operates. Y-27632 targets the Rho-associated protein kinase (ROCK), which is pivotal in actin cytoskeleton reorganization, consequently influencing TMSB15L's role in actin dynamics. SMIFH2 and CK-636, by inhibiting formin-mediated actin polymerization and Arp2/3 complex-mediated nucleation, respectively, can affect the formation of actin structures essential for TMSB15L's function.